Lantheus Holdings, Inc. (NASDAQ:LNTH) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET

Company Participants

Mark Kinarney - VP, IR

Mary Heino - President and CEO

Paul Blanchfield – COO

Robert Marshall - CFO and Treasurer

Conference Call Participants

Roanna Ruiz - SVB Securities

Larry Solow - CJS Securities

Anthony Petrone - Mizuho Group

Richard Newitter - Tuist

Matt Taylor - Jefferies

Justin Walsh - Jones Trading

Yuan Zhi - B. Riley

Operator

Good morning, and welcome to the Lantheus Third Quarter 2022 Conference Call. This is your operator for today's call.

[Operator Instructions]

I will now turn the call over to our host for today, Mr. Mark Kinarney, Vice President of Investor Relations. Mark?

Mark Kinarney

Thank you, and good morning. Welcome to Lantheus' Third Quarter 2022 Conference Call. With me on today's call are Mary Anne Heino, our President and CEO; Bob Marshall, our Chief Financial Officer; and Paul Blanchfield, our Chief Operating Officer. Mary Anne will begin the call with introductory remarks and then turn the call over to Paul for an operational update. Bob will cover our financial results and updated guidance, then we will open the call for Q&A, and finally Mary Anne will provide closing remarks.

This morning we issued a press release, which was furnished to the Securities and Exchange Commission under Form 8-K released in the Investors section of our website at lantheus.com. For those of you not on the webcast, you can find the slide presentation in the Investors section of our website under the Presentations tab.

Before we get started, I would like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by forward-looking statements due to a variety of risks and uncertainties. Please note that we assume no obligation to update these forward-looking statements, except as required by applicable law, even if actual results or future expectations change materially. Please refer to our SEC filings for a detailed discussion of these risks and uncertainties. Also, discussions during -- discussions during this call will include certain non-GAAP financial measures. Reconciliation of these measures to the most directly comparable GAAP financial measures is also included in the Investors section of our website.

With that, it's my pleasure to now turn the call over to Mary Anne.

Mary Heino

Thank you, Mark, and good morning to everyone joining us. We delivered an exceptional third quarter as we continue to find, fight, and follow disease to deliver better patient outcomes. Our strategy to accelerate growth and diversify our portfolio and revenue streams which we outlined at the beginning of this year is succeeding. I am pleased to note we reported revenue of $239.3 million, up more than 134% year-over-year. I'll take a few minutes now to highlight some of our recent progress across our portfolio.